Cromwell Holdings’s Jazz Pharmaceuticals JAZZ Stock Holding History

Cromwell Holdings’s Portfolio JAZZ Stock Details JAZZ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$3.37K	Buy	14 +5	+56%	+$1.09K	﹤0.01%	740
2026 Q1	$1.7K	Buy	9 +3	+50%	+$524	﹤0.01%	747
2025 Q4	$1.02K	Hold	6	–	–	﹤0.01%	821
2025 Q3	$791	Hold	6	–	–	﹤0.01%	884
2025 Q2	$637	Buy	6 +5	+500%	+$543	﹤0.01%	926
2025 Q1	$124	Buy	+1	New	+$130	﹤0.01%	818

Other funds holding JAZZ

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

ACM

Argent Capital Management St Louis, Missouri $3.17B AUM 36.16% 1-Year Est. Return

WCM

Wedge Capital Management Charlotte, North Carolina $6.06B AUM 47.24% 1-Year Est. Return

Perpetual Ltd Sydney, New South Wales, Australia $7B AUM 19.75% 1-Year Est. Return

SAM

Simplify Asset Management Las Vegas, Nevada $7.19B AUM 6.88% 1-Year Est. Return

HWAM

Hennion & Walsh Asset Management Parsippany, New Jersey $3.5B AUM 41.95% 1-Year Est. Return

BCM

BTC Capital Management Des Moines, Iowa $1.65B AUM 27.85% 1-Year Est. Return

SOADOR

State of Alaska Department of Revenue Juneau, Alaska $10.1B AUM 42.83% 1-Year Est. Return

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

AAP

Ardsley Advisory Partners Stamford, Connecticut $960M AUM 207.76% 1-Year Est. Return

Cromwell Holdings's JAZZ Position: Q2 2026 in Review

Cromwell Holdings increased its Jazz Pharmaceuticals (JAZZ) stake by 56% in Q2 2026, buying an estimated $1.09K and bringing the position to 14 shares worth $3.37K. The position accounts for ﹤0.01% of the portfolio, ranked #740.

Cromwell Holdings first reported a position in JAZZ in Q1 2025 and has held it in 6 quarters since. 87 funds tracked by Wall St. Rank hold JAZZ as of Q2 2026.

Cromwell Holdings held 14 shares of Jazz Pharmaceuticals worth $3.37K as of Q2 2026.
Cromwell Holdings bought 5 Jazz Pharmaceuticals shares in Q2 2026, an estimated $1.09K.
Jazz Pharmaceuticals made up ﹤0.01% of Cromwell Holdings's portfolio in Q2 2026, its #740 holding.
Cromwell Holdings first reported a position in Jazz Pharmaceuticals in Q1 2025 and has held it in 6 quarters since.
87 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q2 2026.

Based on Cromwell Holdings's 13F filing for Q2 2026, filed 14 Jul 2026.